NOC vs SCNI · P/E 17, rev $20.76B vs P/E 0.2, rev $1.3M
Northrop Grumman Corporation (NOC) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the NOC and SCNI stock pages for the full models.
Not investment advice.